Facebook-f Linkedin-in

Illiquid Gold: Creative Dealmaking in Biotech (Webinar Evaluate / Treehill Partners)

Illiquid Gold: Creative Dealmaking in Biotech (Webinar Evaluate / Treehill Partners)

Evaluate and Treehill Partners discuss the state of play and look for smart ways to get investment and deals moving as we head into 2023.

Cem Baydar and Paul Verdin from Evaluate are joined by Ali Pashazadeh, Max Baumann, and Mark Mayhew from Treehill Partners to discuss the latest dealmaking data, the pipeline pitfalls to avoid, and more.

View the webinar to get insights on:

  • The latest IPO, M&A, and share price data
  • How a changing ecosystem requires innovative intervention
  • Optimal deal structures
  • The importance of good preparation and due diligence
  • POSTED IN:
BACK TO MAIN PAGE

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Copyright © 2023 Treehill Partners – All Rights Reserved
Facebook-f Linkedin-in